-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

632.P1.80 632. Chronic Myeloid Leukemia: Therapy: Poster I

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, Biological, Diseases, Therapies, CML, Mechanisms, Technology and Procedures, Study Population, Clinically relevant, Myeloid Malignancies, TKI, NGS, vaccines, signal transduction
Saturday, December 9, 2017: 5:30 PM-7:30 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center)

Mariella D'adda1*, Mirko Farina, MD1*, Francesca Schieppati, MD1*, Elisa Cerqui, MD1*, Giuseppina Ruggeri, MD2*, Samantha Ferrari, MD1*, Chiara Bottelli, MD1*, Chiara Pagani, MD1*, Angela Passi, MD1* and Giuseppe Rossi, MD3

1Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
2Laboratorio Analisi, ASST Spedali Civili di Brescia, Brescia, Italy
3Department of Hematology, Spedali Civili, Brescia, Italy

Jorge E. Cortes, MD1, Dong-Wook Kim, MD, PhD2, Hagop M. Kantarjian, MD1, Michael J. Mauro, MD3, Jean M. Aguiar, RN4*, Fiona An, MD4, Eric Leip, PhD5*, Carlo Gambacorti-Passerini, MD6 and Tim H. Brummendorf, MD7

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Seoul St. Mary’s Hospital, Leukemia Research Institute, The Catholic University of Korea, Seoul, KOR
3Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, New York, NY
4Pfizer, New York, NY
5Pfizer, Cambridge, MA
6Hematology Unit, ASST-Monza, University of Milano Bicocca, Monza, MB, Italy
7Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, University Medical Center Aachen, Aachen, Germany

Hélène Haguet, MSc1,2*, Jonathan Douxfils3*, Christian J. Chatelain, MD4, Carlos Graux5*, Francois Mullier, PharmD6* and Jean-Michel Dogné1*

1Department of Pharmacy, University of Namur, Namur, Belgium
2Hematology laboratory, CHU UCL Namur, Yvoir, Belgium
3Department of pharmacy, University of Namur, Namur, BEL
4Department of pharmacy, University of Namur, Namur, Belgium
5Université catholique de Louvain, CHU UCL Namur (site Godinne), Godinne, Belgium
6CHU UCL Namur, Yvoir, BEL

Hélène Haguet, MSc1,2*, Jonathan Douxfils3*, Christian J. Chatelain, MD4, Carlos Graux5*, Francois Mullier, PharmD6* and Jean-Michel Dogné1*

1Department of Pharmacy, University of Namur, Namur, Belgium
2Hematology laboratory, CHU UCL Namur, Yvoir, Belgium
3Department of pharmacy, University of Namur, Namur, BEL
4Department of pharmacy, University of Namur, Namur, Belgium
5Université catholique de Louvain, CHU UCL Namur (site Godinne), Godinne, Belgium
6CHU UCL Namur, Yvoir, BEL

Won-Sik Lee, MD, PhD1, Hye-Young Song2*, Hyeoung-Joon Kim3, Jee Hyun Kong, MD4*, Young Rok Do, MD, PhD5, Jae-Yong Kwak6, Sukjoong Oh, MD, PhD7, Sung-Hyun Kim, MD, PhD8, Jeong-A Kim9, Dae Young Zang, MD, PhD10*, Yeung-Chul Mun, MD, PhD11*, Young-Woong Won12*, Sung-Eun Lee, MD13*, Yunsuk Choi, MD14* and Dong-Wook Kim, MD, PhD15

1Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea, Republic of (South)
2The Catholic University of Korea, Leukemia Research Institute, Seoul, South Korea
3Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Korea, Republic of (South)
4Department of Hematology Oncology, Wonju College of Medicine, Yonsei University, Wonju, South Korea
5Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of (South)
6Division of Hematology-Oncology, Chonbuk National University Medical School, Chonbuk National University Hospital, Jeonju, Korea, Republic of (South)
7Division of Hematology-Oncology, School of Medicine, Sungkyunkwan University, Kangbuk Samsung Hospital, Seoul, Korea, Republic of (South)
8Dong-A University Hospital, Busan, KOR
9Department of Hematology, The Catholic University of Korea, St. Vincent’s Hospital, Suwon, Korea, Republic of (South)
10Hallym University Sacred Heart Hospital, Anyang, KOR
11Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea, Republic of (South)
12Division of Hematology and Oncology, Hanyang Univerysity College of Medicine, Hanyang University Guri Hospital, Guri, Korea, Republic of (South)
13Division of Hematology, Seoul, St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
14Department of Hematology, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, South Korea
15Catholic Blood and Marrow Transplantation Center, Division of Hematology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)

Kamal Chamoun, MD1*, Hagop M. Kantarjian, MD1, Mary Abisola Akosile, PhD2*, Rita Assi, MD2*, Farhad Ravandi, MBBS3, Gautam Borthakur, MD1, Guillermo Garcia-Manero, MD1, Tapan Kadia, MD1, Marina Konopleva, MD, PhD4, Zeev Estrov, MD5, Courtney D. DiNardo, MD, MSc6, Naval Daver, MD1, Naveen Pemmaraju, MD2, Alessandra Ferrajoli, MD2, Jan A. Burger, MD, PhD 7, William Wierda, MD2*, Elias J. Jabbour, MD 8 and Jorge E. Cortes, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Leukemia department, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
5University of Texas M.D. Anderson Cancer Center, Houston, TX
6The University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Leukemia, MD Anderson Cancer Center, Houston, TX
8Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX

Katia B Pagnano, MD1, Eliana C Miranda1*, Marcia Torresan Delamain2*, Gislaine Oliveira Duarte, MD1*, Bruna Virgilio1*, Jessica Vianna1*, Erich Vinicius De Paula, MD, PhD 1 and Carmino Antonio De Souza, MD, PhD1*

1Centro de Hematologia e Hemoterapia, University of Campinas, Campinas, Brazil
2Centro de Hematologia e Hemoterapia, University of Campinas, Sao Paulo, Brazil

Katia B Pagnano, MD1, Eliana C Miranda1*, Fernanda S Seguro, MD2*, Gustavo HR Magalhaes, MD3*, Nelma D Clementino, MD3*, Arthur Moellmann-Coelho, MD4*, Maryanna N Da Silva5*, Renato Centrone, MD6*, Monika Conchon, MD7*, Jaisson Bortolini, MD8*, Teresa Cristina Bortolheiro, MD9*, Valquiria Povoa1*, Luciana Nardinelli2*, Carmino Antonio De Souza, MD, PhD1* and Israel Bendit, MD, PhD10*

1Centro de Hematologia e Hemoterapia, University of Campinas, Campinas, Brazil
2University of São Paulo, São Paulo, Brazil
3Hospital das Clínicas - UFMG, Belo Horizonte, Brazil
4Nacional Cancer Institute of Brazil, Rio de Janeiro, Brazil
5Instituto Nacional do Câncer, Rio de Janeiro, Brazil
6Instituto Hemomed de Oncologia e Hematologia, Sao Paulo, Brazil
7Hospital Santa Marcelina, Sao Paulo, Brazil
8CEPON, Florianopolis, Brazil
9Santa Casa de São Paulo, São Paulo, Brazil
10University of São Paulo, Sao Paulo, Brazil

David M Ross, MBBS, PhD, FRACP, FRCPA1,2,3,4,5*, Ilaria S Pagani, PhD1*, Naranie Shanmuganathan, MBBS2, John F Seymour, MBBS, PhD3,6, Anthony K Mills, FRACP, FRCPA, MBBS3,7, Robin J Filshie, PhD, FRACP, FRCPA3,8, Christopher K Arthur, MD, FRACP, FRCPA, MBBS3,9, Phuong Dang1*, Verity A Saunders1*, Jody Braley10*, David T Yeung, PhD, BSc, FRACP, FRCPA, MBBS1,2,3,5, Deborah L White, PhD, FRCPath3,11,12, Andrew P Grigg, MBBS, MD, FRACP, FRCPA3,13*, Anthony P Schwarer, MD, MBBS (Hons), FRACP, FRCPA3,14, Susan Branford, PhD10,12,15,16 and Timothy P. Hughes, MD1,2,3,5

1Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, Australia
2Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, Australia
3Australasian Leukaemia and Lymphoma Group, Melbourne, Australia
4Haematology and Genetic Pathology, Flinders University, Adelaide, Australia
5School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, Australia
6Peter MacCallum Centre & Royal Melbourne Hospital, Melbourne, Australia
7Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia
8Department of Haematology, St. Vincent's Hospital Melbourne, Melbourne, Australia
9Department of Haematology, Royal North Shore Hospital, Sydney, Australia
10Genetic and Molecular Pathology, Centre for Cancer Biology, SA Pathology, Adelaide, Australia
11Cancer Theme, SAHMRI, Adelaide, SA, Australia
12School of Biological Sciences. Faculty of Sciences, University of Adelaide, Adelaide, Australia
13Department of Clinical Haematology, Austin Hospital and Olivia Newton John Cancer Research Institute, Melbourne, Australia
14Department of Haematology, The Alfred Hospital and Box Hill Hospital, Melbourne, Australia
15School of Medicine, Faculty of Health Sciences, SA Pathology, Adelaide, SA, Australia
16School of Pharmacy and Medical Science, University of South Australia, Adelaide, Australia

Giuseppe Saglio, MD, PhD1, Timothy P. Hughes, MD2, Andreas Hochhaus, MD3, Dong-Wook Kim, MD, PhD4, Francis J. Giles, MD, FRCPI, FRCPath5, Jerald P. Radich, MD6, David M Ross, MBBS, PhD, FRACP, FRCPA2*, Prashanth Gopalakrishna, MD7*, Weiping Deng8*, Rafik Fellague-Chebra, MD9*, Sandip Acharya, MSc10* and Francois-Xavier Mahon, MD, PhD11

1University of Turin, Orbassano, Torino, Italy
2SA Pathology and South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia
3Abteilung Hämatologie/Onkologie, Universitätsklinikum Jena, Jena, Germany
4Catholic Blood and Marrow Transplantation Center, Division of Hematology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
5Northwestern Medicine Developmental Therapeutics Institute, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
6Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
7Novartis Pharma AG, Basel, Switzerland
8Novartis Pharmaceuticals Corporation, East Hanover, NJ
9Novartis Pharma S.A.S., Rueil-Malmaison, France
10Novartis Health Care Pvt. Ltd., Hyderabad, India
11Cancer Center of Bordeaux, Institut Bergonié, INSERM U1218, University of Bordeaux, Bordeaux, France

Shun Liao1*, Taehyung Kim, MSc2, Hyeoung-Joon Kim3, Jae-Sook Ahn3,4*, Jaehyuk Choi5, Yeo-Kyeoung Kim5*, Yoon-Sang Kim5, Seung-Shin Lee, MD3*, Zhaolei Zhang, PhD6* and Dennis Kim, MD7

1Computer Science, University of Toronto, Toronto, ON, Canada
2Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada
3Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Korea, Republic of (South)
4Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun-Gun, Korea, Republic of (South)
5Genome Research Center for Hematopoietic Disease, Chonnam National University Hwasun Hospital, Hwasun, Korea, Republic of (South)
6Department of Computer Science, University of Toronto, Toronto, ON, Canada
7Blood and Marrow Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada

Fiorina Giona, MD1, Michelina Santopietro, MD1*, Giuseppe Menna, MD2*, Concetta Micalizzi, MD3*, Maria Caterina Putti, MD4*, Nicola Santoro, MD5*, Ottavio Ziino, MD6*, Rosamaria Mura, MD7*, Saverio Ladogana, MD8*, Grazia Iaria, MD9*, Antonella Sau, MD10*, Roberta Burnelli, MD11*, Nadia Vacca, MD12*, Margherita Nardi, MD13*, Caterina Consarino, MD14*, Eleonora Miulli, MD1*, Maria Luisa Moleti, MD1*, Fara Petruzziello, MD2*, Sonia Maria Orlando15*, Andrea Biondi, MD16, Franco Locatelli, MD, PhD17, Giuseppe Saglio, MD, PhD18 and Robin Foa, MD1

1Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Policlinico Umberto I, Rome, Italy
2Pediatric Hematology, Pausilipon Hospital, Naples, Italy
3Clinical Experimental Hematology Unit, Gaslini Research Institute, Genova, ITA
4Department for Children’s and Women’s Health, University of Padua, Padua, ITA
5Department of Pediatrics, Policlinico di Bari, Bari, Italy
6Pediatric Hematology and Oncology, ARNAS Ospedale Civico di Palermo, Palermo, Italy
7Pediatric Hemato-Oncology Unit, Ospedale Regionale per le Microcitemie, Cagliari, Italy
8Department of Pediatrics, "Casa Sollievo della Sofferenza" Hospital, San Giovanni Rotondo, Italy
9Hematology, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria, Italy
10Pediatric Hematology-Oncology Unit, Ospedale Civico, Pescara, Italy
11Pediatric Hemato-Oncology Unit, Sant'Anna Hospital, Ferrara, Italy
12Pediatric Unit, Ospedale di Sassari, Sassari, Italy
13Pediatric Hemato-oncology Unit, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy
14Hemato-Oncology Unit, Pugliese-Ciaccio Hospital, Catanzaro, Italy
15GIMEMA Foundation, Rome, Italy
16University of Milano-Bicocca, San Gerardo Hospital/Fondazione MBBM, Monza, Italy
17Department of Pediatric Hematology and Oncology, Bambino Gesù Children's Hospital, Rome, Italy
18Department of Clinical and Biological Sciences, University of Turin, Orbassano, Turin, Italy

Markus Pfirrmann1*, Francois-Xavier Mahon, MD, PhD2, Joelle Guilhot, PhD3, Johan Richter, MD, PhD4*, Francis J. Giles, MD, FRCPI, FRCPath5, Andreas Hochhaus, MD6, Jerald P. Radich, MD7*, David M Ross, MBBS, PhD, FRACP, FRCPA8*, Giuseppe Saglio, MD, PhD9, Weiping Deng10*, Darshan Dalal, MPH, MD, PhD10* and Susanne Saussele, MD 11

1Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians-University, Munich, Germany
2INSERM U1218, University of Bordeaux, Cancer Center of Bordeaux, Institut Bergonié, Bordeaux, France
3Inserm CIC 1402, CHU de Poitiers, Poitiers, France
4Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden
5NMDTI, Robert H. Lurie Comprehensive Cancer Center of Northwestern Universit, Chicago, IL
6Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany
7Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
8Flinders University, Bedford Park, Australia
9University of Turin, Dept. of Clinical and Biological Sciences, Orbassano, Italy
10Novartis Pharmaceuticals Corporation, East Hanover, NJ
11Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany

Bhagwan Yadav, PhD1,2*, Mette Ilander, PhD1,2*, Anna Kreutzman, PhD1,2*, Henrik Hjorth-Hansen, MD3,4,5 and Satu Mustjoki, MD, PhD1,2

1Hematology Research Unit Helsinki, University of Helsinki and Department of Hematology, Helsinki University Hospital Comprehensive Cancer Centre, Helsinki, Finland
2Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland
3St. Olav's Hospital - Trondheim Univ. Hosp., Trondheim, NOR
4Department of Cancer Research and Molecular Medicine (IKM), Norwegian University of Science and Technology (NTNU), Trondheim, Norway
5On behalf of Nordic CML Study Group, Trondheim, Norway

Yi-Jiun Su, MD1*, Ming-Chung Kuo, MD1,2*, Chieh-Lin Teng, MD3*, Tsai-Yun Chen, MD4*, Ming-Chun Ma, MD5*, Pei-Ching Hsiao, MD6*, Ming-Chung Wang, MD5*, Tung-Huei Lin, MS1*, Wen-Li Hwang, MD3*, Chih-Cheng Chen, MD7*, Youngsen Yang, MD3*, Sung-Nan Pei, MD5, Yen-Min Huang, MD8*, Sin-Syue Li, MD4*, Ming-Yang Lee, MD9*, Hung-I Cheng, MD10* and Lee-Yung Shih, MD1,2

1Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan
2Chang Gung University, Taoyuan, Taiwan
3Taichung Veterans General Hospital, Taichung, Taiwan
4National Cheng Kung University Hospital, Tainan, Taiwan
5Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung, Taiwan
6Chung Shan Medical University Hospital, Taichung, Taiwan
7Chang Gung Memorial Hospital at Chiayi, Chiayi, Taiwan
8Chang Gung Memorial Hospital at Keelung, Keelung, Taiwan
9Chia-Yi Christian Hospital, Chiayi, Taiwan
10Hsinchu Mackay Memorial Hospital, Hsinchu, Taiwan

Fausto Castagnetti, MD, PhD1, Gabriele Gugliotta, MD, PhD2, Massimo Breccia, MD3*, Federica Sorà, MD4*, Alessandra Iurlo, MD, PhD5*, Antonella Gozzini, MD6*, Anna Rita Scortechini, MD7*, Luigia Luciano, MD8, Fabio Stagno, MD, PhD9, Alessandra Malato, MD10*, Elisabetta Abruzzese, MD11, Monica Crugnola, MD12*, Patrizia Pregno, MD13*, Giorgina Specchia, MD14, Pellegrino Musto, MD15*, Nicola Cascavilla, MD16*, Mario Tiribelli, MD17*, Massimiliano Bonifacio, MD18*, Piero Galieni, MD19*, Fausto Palmieri, MD20*, Simona Soverini, PhD21, Maria Teresa Bochicchio22*, Simona Sica, MD23*, Robin Foà, MD24*, Michele Cavo, MD25*, Giovanni Martinelli, MD26, Giuseppe Saglio, MD, PhD27, Fabrizio Pane, MD28, Michele Baccarani, MD29 and Gianantonio Rosti, MD30*

1Institute of Hematology "L. and A. Seràgnoli", Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, "S. Orsola-Malpighi" Hospital, Bologna, Italy
2Department of Experimental Diagnostic and Specialty Medicine - DIMES Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Bologna, Italy
3Dipartimento Biotecnologie Cellulari, University of Rome “Sapienza”, Roma, Italy
4Hematology Unit, Policlinico “A. Gemelli”, Università Cattolica del Sacro Cuore, Roma, Italy
5Hematology Division, IRCCS Cà Granda - Maggiore Policlinico Hospital Foundation, Milano, Italy
6SC Terapie Cellulari e Medicina Trasfusionale, AOU Careggi, Florence, Italy
7Hematology Unit, A.O.U. Ospedali Riuniti, Ancona, Italy
8Hematology - Department of Clinical Medicine and Surgery, Federico II University, Napoli, Italy
9Hematology Section, Biomedical Sciences, University of Catania, Trecastagni, ITA
10UOC di Ematologia con UTMO, Ospedali Riuniti Villa Sofia-Cervello, Palermo, ITA
11Hematology Unit, S.Eugenio Hospital, Tor Vergata University, Rome, ITA
12Division of Hematology, University Hospital of Parma, Parma, Italy
13AZ OSP CITTA' DELLA SALUTE E SCIENZA TORINO, University of Torino, TORINO, Italy
14University of Bari, Department of Emergency and Organ Transplantation (D.E.T.O.), Hematology Section, Bari, Italy
15IRCCS CROB, Referral Cancer Center of Basilicata, Rionero In Vulture, ITA
16Casa Sollievo Della Sofferenza IRCCS, San Giovanni Rotondo, Italy
17Division of Hematology and BMT, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
18Department of Medicine, Section of Haematology, University of Verona, Verona, Italy
19U.O.C. Ematologia e Terapia Cellulare, Ospedale Mazzoni, Ascoli Piceno, Italy
20Hematology Unit, Ospedale “S. G. Moscati”, Avellino, Italy
21Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Castel Maggiore, Bologna, Italy
22Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "L. and A. Seràgnoli", University of Bologna, "S. Orsola-Malpighi" Hospital, Bologna, Italy
23Hematology Unit, Fondazione Policlinico Universitario A Gemelli Università Cattolica, Roma, Italy
24Hematology Unit, Sapienza University of Rome, Rome, Italy
25Department of Physics and Astronomy, University of Bologna, Bologna, Italy
26Institute of Hematology 'Seragnoli', Institute of Hematology 'Seragnoli', Bologna, Italy
27University of Turin, Orbassano, Torino, Italy
28Hematology - Departments of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
29Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Bologna, Italy
30Department of Experimental, Diagnostic and Specialty Medicine - DIMES, Institute of Hematology "L. and A. Seràgnoli", S.Orsola-Malpighi University Hospital, Bologna, Italy

Lu Yu, MD* and Qian Jiang, MD

Peking University Institute of Hematology, Peking University People's Hospital, Beijing, China

Fabio Stagno, MD, PhD1, Roberto Latagliata2*, Mario Annunziata, MD3*, Elisabetta Abruzzese, MD4, Fausto Castagnetti, MD5, Alessandra Iurlo, MD, PhD6*, Monica Bocchia, MD7*, Monica Crugnola, MD8*, Nicola Sgherza9*, Attilio Guarini, MD10*, Federica Sorà, MD11*, Isabella Capodanno12*, Carmen Fava, MD, PhD13*, Antonella Gozzini, MD14*, Massimiliano Bonifacio, MD15*, Sabrina Crescenzi Leonetti, MD16*, Sara Galimberti, PhD, MD17*, Costanzo Feo, MD18*, Enrico Montefusco19*, Mario Tiribelli, MD20*, Patrizia Pregno, MD21*, Micaela Bergamaschi, MD22*, Manuela Rizzo, M.D.23*, Agostino Antolino24*, Endri Mauro, MD25*, Antonella Russo Rossi, MD26*, Bruno Martino27*, Raffaele Palmieri, MD28*, Maria Rosaria Esposito, MD29*, Maria Iovine, MD30*, Paolo Danise31*, Antonello Sica, MD32*, Paolo Vigneri, MD, PhD33*, Massimo Breccia, MD34*, Gianantonio Rosti, MD35*, Robin Foa, MD36 and Luigiana Luciano37*

1Chair and Hematology Section, Ferrarotto Hospital, Catania, Italy
2Department of Cellular Biotechnologies and Hematology, Hospital, Rome, Italy
3Hematology, Ospedale Cardarelli, NAPOLI, Italy
4Hematology Unit, S.Eugenio Hospital, Tor Vergata University, Rome, ITA
5Hematology/Oncology "Seragnoli", University of Bologna, Bologna, Italy
6Hematology Division, IRCCS Cà Granda - Maggiore Policlinico Hospital Foundation, Milano, Italy
7Azienda Ospedaliera Universitaria, University of Siena, Siena, Italy
8Division of Hematology, University Hospital of Parma, Parma, Italy
9Division of Hematology, IRCCS Ospedale Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
10Hematology Unit – Oncological Department, Istituto Tumori Giovanni Paolo II I.R.C.C.S. Ospedale Oncologico, Bari, Bari, Italy
11Institute of Hematology, Catholic University of Rome, Rome, Italy
12Hematology Unit, Arcispedale Santa Maria Nuova IRCCS, Reggio Emilia, Italy
13Department of Clinical and Biological Sciences, University of Turin, Orbassano, Turin, Italy
14SC Terapie Cellulari e Medicina Trasfusionale, AOU Careggi, Florence, Italy
15Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
16Hematology, Sandro Pertini Hospital, Rome, Italy
17Hematology Division, AOUP, Pisa, Italy
18Hematology, Rummo Hospital, Benevento, Italy
19POLICLINICO ST. ANDREA, ROME, ITA
20Division of Hematology and BMT, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
21AZ OSP CITTA' DELLA SALUTE E SCIENZA TORINO, University of Torino, TORINO, Italy
22Division of Hematology 1, IRCCS AOU San Martino-IST, Genova, Italy
23Hematology, Tor Vergata University, Rome, Italy
24Hematology, ASP7, Ragusa, ITA
25Department of Internal Medicine, General Hospital, Pordenone, Italy
26Hematology, University of Bari, Bari, ITA
27Haematology Dept.- Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, Italy
28Hematology, Moscati Hospital, Avellino, Italy
29Hematology Unit, Ascalesi Hospital, Naples, ITA
30Hematology - Oncology Unit, Sant'Anna San Salvatore Hospital, Caserta, Italy
31Hematology, Pagani Hospital, Salerno, Italy
32Hematology Unit, Luigi Vanvitelli University, Naples, Italy
33Dep. Clinical and Experimental Medicine, University of Catania Medical School, Catania, Italy
34Dipartimento Biotecnologie Cellulari, University of Rome “Sapienza”, Roma, Italy
35Department of Experimental, Diagnostic and Specialty Medicine - DIMES, Institute of Hematology "L. and A. Seràgnoli", S.Orsola-Malpighi University Hospital, Bologna, Italy
36Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Policlinico Umberto I, Rome, Italy
37AOU Università degli Studi di Napoli "Federico II", Napoli, Italy

Jee Hyun Kong, MD1*, Elliott F. Winton, MD2, Leonard Heffner, MD3, Manila Gaddh, MD4, Brittany Hill, PA-C, MMSc, MSc, MPH5*, Martha Arellano, MD4, Fuad El-Rassi5*, Audrey Kim5*, Anand Jillella, MD4* and Vamsi K Kota5*

1Department of Hematology Oncology, Wonju College of Medicine, Yonsei University, Wonju, South Korea
2Winship Cancer Institute Emory Univ. School of Med., Atlanta, GA
3Hematology/Winship Cancer Institute, Atlanta, GA
4Winship Cancer Institute of Emory University, Atlanta, GA
5Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, atlanta, GA

Mamta Sumi Sumi, PhD1*, Guru Ahmad2*, Musadiq Ahmad Bhat, MSc.3*, Ab. Rashid Rashid, Ph.D4*, Mariyam Zuberi, Ph.D5*, Naresh Gupta6* and Mamta P Sumi, MD7*

1Biochemistry, Maulana azad medical college, new delhi, India
2biochemistry, maulana azad medical college, New Delhi, Delhi, India
3Biochemistry, Maulana azad medical college, New Delhi, India
4university of Tabuk, Saudi, Saudi Arabia
5biochemistry, Maulana azad medical college, New Delhi, India
6Medicine, maulana azad medical college, Delhi, IN, India
7maulana azad medical college, Delhi, IN, India

Koji Sasaki, MD1, Hagop M. Kantarjian, MD1, Susan M. O'Brien, MD2, Farhad Ravandi, MBBS3, Marina Konopleva, MD, PhD4, Gautam Borthakur, MD1, Guillermo Garcia-Manero, MD1, William G Wierda, MD, PhD1, Naval Daver, MD1, Alessandra Ferrajoli, MD5, Koichi Takahashi, MD6, Preetesh Jain, MBBS, MD, DM, PhD1, Mary B. Rios, RN7*, Sherry Pierce, BSN, BA1*, Elias J. Jabbour, MD 8 and Jorge E. Cortes, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2University of California Irvine, Chao Family Comprehensive Cancer Center, Orange, CA
3Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
5Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
6Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
7MD Anderson Cancer Center, Houston, TX
8Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX

Christophe Ferrand, PhD1, Marina Deschamps, PhD2*, Alba Levitas3*, Christina Lockwood, PhD4*, Jacqueline E. Payton, MD, PhD5, Geoffrey L. Uy, MD6, Charles A. Schiffer, MD7, Gerald Feldman, MD8*, Aaron Bossler, MD, PhD9, Julie Woolworth, PhD10*, Alice S. Mims, MD, MSCR11, Krupa Shridhar3*, Natalie Wu, PhD3*, Sandy Huang3*, Huilin Wei, MD, PhD3*, Chris Lykke, PhD12*, Michael P. Bates, MD13, Wendy Wong3* and Gwo-Jen Day, PhD3*

1University hospital Besancon, University Franche Comte, Besancon, France
2University hospital Besancon, University Franche Comte, Besancon, FRA
3Oncology R&D, Cepheid, Sunnyvale, CA
4Department of Laboratory Medicine, University of Washington, Seattle, WA
5Washington Univ. in St. Louis, Saint Louis, MO
6Washington University School of Medicine, Saint Louis, MO
7Karmanos Cancer Institute, Wayne State University, Detroit, MI
8Department of Pathology, Wayne State University School of Medicine and Detroit Medical Center University Laboratory, Detroit, MO
9University of Iowa Carver College of Medicine, Iowa City, IA
10Department of Pathology & Laboratory Medicine, Medical University of South Carolina, Charleston, SC
11Division of Hematology, Department of Internal Medicine, The Ohio State University James Comprehensive Cancer Center, Columbus, OH
12Data Management and Analytics, Cepheid, Sunnyvale, CA
13Medical and Scientific Affairs and Strategy, Cepheid, San Carlos, CA

Kiran Naqvi, MD, MPH1, Jorge E. Cortes, MD1, Jeffrey Skinner, MHA1*, Elias J. Jabbour, MD 1, Naveen Pemmaraju, MD2, Prithviraj Bose, MD3, Philip A Thompson, MBBS2*, Gautam Borthakur, MD1, Zeev Estrov, MD1 and Hagop M. Kantarjian, MD2

1Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, MD Anderson Cancer Center, Houston, TX

Louise Caldwell, BSc1*, Simone Claudiani, MD2*, Dragana Milojkovic, MBBS, PhD3*, Richard Szydlo, PhD2*, Elisabetta Abruzzese, MD4, George Nesr, MD2*, Michael J. Mauro, MD5, Renuka Palanicawander, MD3*, Aoife Gatenby, BSc2*, Ira Sabli, BSc2*, Jamshid S Khorashad, MD, PhD6*, Letizia Foroni, MD, PhD2* and Jane F. Apperley, FRCP, FRCPath, MD, MBChB2

1Medical School, University of Birmingham, Birmingham, United Kingdom
2Centre for Haematology, Imperial College London at Hammersmith Hospital, London, United Kingdom
3Department of Haematology, Hammersmith Hospital (Imperial College Healthcare NHS Trust), London, United Kingdom
4Hematology Unit, S.Eugenio Hospital, Tor Vergata University, Rome, ITA
5Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, New York, NY
6North West London Pathology, London, United Kingdom

Tatsuro Jo, MD, PhD, Sadaharu Irie*, Kazuhiro Noguchi*, Shizuka Hayashi*, Risa Hayase*, Haruna Shioya*, Yohei Kaneko*, Kensuke Horio, MD* and Jun Taguchi, MD, PhD*

Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan

Mario Tiribelli, MD*, Sara Di Giusto*, Eleonora Toffoletti*, Davide Griguolo*, Domenico Penna*, Giorgia Maccari*, Marta Medeot*, Renato Fanin* and Daniela Damiani*

Division of Hematology and BMT, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy

Thoralf Lange, MD1,2*, Rainer Krahl, PhD2*, Ulrich von Grünhagen, MD3*, Haifa Kathrin Al-Ali4,5*, Schwarzer Andreas, MD6*, Kathleen Jentsch-Ulrich, MD7*, Claudia Spohn, MD8*, Volker Lakner, MD9*, Michael Assmann, MD10*, Christian Junghanss, MD11*, Markus Pfirrmann12*, Arthur Gil, PhD13*, Rüdiger Hehlmann, MD14, Michael W. Deininger, MD, PhD15 and Dietger Niederwieser, MD16

1Asklepios Klinikum Weissenfels, Weissenfels, Germany
2Abteilung Hämatologie und Onkologie, Universität Leipzig, Leipzig, Germany
3Gemeinschaftspraxis Hämatologie und Onkologie, Cottbus, Germany
4Universitätsklinikum Halle, Halle (Saale), Germany
5Universitätsklinikum Leipzig, Leipzig, Germany
6Gemeinschaftspraxis für Hämatologie und Onkologie, Leipzig, Germany
7Gemeinschaftspraxis für Hämatologie und Onkologie, Magdeburg, Germany
8Gemeinschaftspraxis für Hämatologie und Onkologie, Halle, Germany
9Gemeinschaftspraxis für Hämatologie und Onkologie, Rostock, Germany
10MVZ Elblandpolikliniken GmbH, Riesa, Germany
11Universitätsmedizin Rostock, Rostock, Germany
12Institut für medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität München, München, Germany
13Institut für medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität, München, Germany
14Medizinische Fakultät Mannheim, ELN-Foundation, Weinheim, DEU
15University of Utah, Salt Lake City, UT
16Department of Hematology, University of Leipzig, Leipzig, Germany

Carmen Fava, MD, PhD1*, Giovanna Rege-Carmbrin1*, Irene Dogliotti2*, Marco Cerrano3*, Paola Berchialla1*, Gianantonio Rosti, MD4*, Fausto Castagnetti, MD, PhD5, Gabriele Gugliotta, MD, PhD6, Bruno Martino7*, Carlo Gambacorti-Passerini, MD8, Elisabetta Abruzzese, MD, PhD9*, Ester Maria Orlandi, MD10*, Chiara Elena11*, Patrizia Pregno12*, Antonella Gozzini, MD13*, Paolo Avanzini, MD14*, Micaela Bergamaschi, MD15*, Monica Crugnola, MD16*, Monica Bocchia, MD17*, Sara Galimberti, PhD, MD18*, Davide Rapezzi, MD19*, Alessandra Iurlo, MD, PhD20*, Daniele Cattaneo, MD21*, Roberto Latagliata22*, Massimo Breccia, M.D., PhD22*, Michele Cedrone, MD23*, Marco Santoro, MD24*, Mario Annunziata, MD25*, Luciano Levato, MD26*, Fabio Stagno, MD, PhD27, Francesco Cavazzini, MD28*, Nicola Sgherza29*, Valentina Giai30*, Luigiana Luciano31*, Sabina Russo32*, Pellegrino Musto, MD33, Giovanni Caocci, MD34*, Federica SORA, MD35*, Francesco Iuliano36*, Francesca Lunghi, MD37*, Giorgina Specchia, MD38, Fabrizio Pane, MD39, Michele Baccarani, MD5*, Dario Ferrero40* and Giuseppe Saglio, MD, PhD41

1Department of Clinical and Biological Sciences, University of Turin, Orbassano (TO), Italy
2Hematology Division, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy
3Department of Molecular Biothecnologies and Health Sciences, Turin, Italy
4Institute of Hematology " L. & A. Seràgnoli",, St. Orsola University Hospital, Bologna, Italy
5Institute of Hematology " L. & A. Seràgnoli", St. Orsola University Hospital, Bologna, Italy
6Department of Experimental Diagnostic and Specialty Medicine - DIMES Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Bologna, Italy
7Azienda Ospedaliera "Bianchi Melacrino Morelli", Reggio Calabria, Italy
8University Milano Bicocca, San Gerardo Hospital, Monza, Italy
9Haematology Unit, S. Eugenio Hospital, Rome, Italy
10Hematology Hunit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
11S.C. Ematologia, Fondazione IRCCS Policlinico S. Matteo - PV, Pavia, Italy
12A.O. Città della Salute e della Scienza di Torino, Turin, Italy
13SC Terapie Cellulari e Medicina Trasfusionale, AOU Careggi, Florence, Italy
14Hematology Unit, S.Maria Nuova Hospital, IRCCS, Reggio Emilia, Italy
15Division of Hematology 1, IRCCS AOU San Martino-IST, Genova, Italy
16Division of Hematology, University Hospital of Parma, Parma, Italy
17Azienda Ospedaliera Universitaria, University of Siena, Siena, Italy
18Hematology Department, University of Pisa, Pisa, Italy
19S.C. Ematologia, ASO S. Croce e Carle, Cuneo, Italy
20Hematology Division, IRCCS Cà Granda - Maggiore Policlinico Hospital Foundation, Milano, Italy
21Oncohematology Division, IRCCS Ca' Granda - Maggiore Policlinico Hospital Foundation, University of Milan, Milano, Italy
22Department of Cellular Biotechnologies and Hematology, University La Sapienza, Rome, Italy
23UOC of Hematology, San Giovanni - Addolorata Hospital, Rome, Italy
24Hematology Unit, Università di Palermo, Palermo, Italy
25Hematology, Ospedale Cardarelli, NAPOLI, Italy
26Department Hematology-Oncology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy
27Chair and Hematology Section, Ferrarotto Hospital, Catania, Italy
28Dipartimento di Scienze Mediche Sezione di Ematologia e Fisiopatologia dell'Emostasi, Ferrara, Italy
29Division of Hematology, IRCCS Ospedale Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
30Ospedale SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
31AOU Università degli Studi di Napoli "Federico II", Napoli, Italy
32Dipartimento di Medicina Interna, AOU Policlinico di Messina, Messina, Italy
33IRCCS, Centro Di Riferimento Oncologico Della Basilicata, Rionero in Vulture, Italy
34Department of Medical Sciences, University of Cagliari, Cagliari, Italy
35HEMATOLOGY DEP, Università Cattolica del Sacro Cuore - Policlinico A. Gemelli, ROMA, Italy
36Presidio Ospedaliero N. Giannetasio - Azienda ASL 3, Rossano (CS), Italy
37U.O. Ematologia e Trapianto di Midollo Osseo, Ospedale San Raffaele IRCCS, Milan, Italy
38U. O. Ematologia con Trapianto – Ambulatorio, Azienda Ospedaliero-Universitaria Policlinico Consorziale di Bari, Bari, Italy
39Hematology - Departments of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
40Dipartimento di Oncologia e Ematologia, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy
41Department of Clinical and Biological Sciences, University of Turin, Orbassano, Turin, Italy

Andreas Hochhaus, MD1, Jorge E. Cortes, MD2, Dong-Wook Kim, MD, PhD3, Javier Pinilla Ibarz, MD, PhD4, Philipp D. le Coutre, MD5, Ronald Paquette, MD6, Charles Chuah, MD7, Franck Emmanuel Nicolini, MD, PhD8, Moshe Talpaz, MD9, Daniel J. DeAngelo, MD, PhD10, Elisabetta Abruzzese, MD, PhD11*, Delphine Rea, MD12, Martin C. Mueller, MD13*, Carlo Gambacorti-Passerini, MD14, Fausto Castagnetti, MD, PhD15, Dragana Milojkovic, MBBS, PhD16*, Stephanie Lustgarten, PhD17*, Victor M. Rivera, PhD17*, Frank Neumann, MD, PhD18, Francois Guilhot, MD19, Michael W. Deininger, MD, PhD20, Timothy P. Hughes, MD, MBBS, FRACP, FRCPA21, Neil P. Shah, MD, PhD22 and Hagop M. Kantarjian, MD23

1Jena University Hospital, Jena, Germany
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea,, Seoul, Korea, Republic of (South)
4H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
5Charité Universitätsmedizin Berlin, Berlin, Germany
6Cedars-Sinai Medical Center, Los Angeles, CA
7Singapore General Hospital and Duke-NUS Medical School, Singapore, Singapore
8Centre Hospitalier Lyon Sud, Pierre Bénite & Centre Léon Bérard, Lyon, France
9Comprehensive Cancer Center, Michigan Medicine, Ann Arbor, MI
10Dana-Farber Cancer Institute, Boston, MA
11S. Eugenio Hospital, Tor Vergata University, Rome, Italy
12Service d'Hématologie adulte et Centre d'Investigation Clinique Hôpital Saint Louis, Paris, France
13Institute for Hematology and Oncology (IHO GmbH), Mannheim, Germany
14University Milano Bicocca, San Gerardo Hospital, Monza, Italy
15University of Bologna, Bologna, Italy
16Department of Haematology, Hammersmith Hospital, Imperial College, London, United Kingdom
17ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
18Takeda Pharmaceutical Company Limited, Cambridge, MA
19Inserm CIC 1402, CHU de Poitiers, Poitiers, France
20Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
21South Australian Health and Medical Research Institute and University of Adelaide, Adelaide, Australia
22University of California, San Francisco, San Francisco, CA
23The University of Texas MD Anderson Cancer Center, Houston, TX

Andreas Hochhaus, MD1, Carlo Gambacorti-Passerini, MD2, Michael W. Deininger, MD, PhD3, Michael J. Mauro, MD4, Charles Chuah, MD5, Dong-Wook Kim, MD, PhD6, Iryna Dyagil, MD PhD7*, Nataliia Glushko8*, Dragana Milojkovic, MBBS, PhD9*, Philipp D. le Coutre, MD10, Valentín García Gutiérrez, PhD11, Laurence Reilly12*, Allison Jeynes-Ellis12*, Rocco J. Crescenzo, DO, FACOI13*, Eric Leip, PhD14*, Nathalie Bardy-Bouxin, PhD15*, Timothy H. Brümmendorf16 and Jorge E. Cortes, MD17

1Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany
2University of Milano-Bicocca, San Gerardo Hospital, Monza, Italy
3University of Utah, Salt Lake City, UT
4Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, New York, NY
5Singapore General Hospital, Duke-NUS Medical School, Singapore, Singapore
6Seoul St. Mary’s Hospital, Leukemia Research Institute, The Catholic University of Korea, Seoul, Korea, Republic of (South)
7Hematology, National Research Center For Radiation Medicine, Kiev, UKR
8Ivano-Frankivsk Regional Clinical Hospital, Ivan0-Frankivsk, Ukraine
9Department of Haematology, Hammersmith Hospital, Imperial College, London, United Kingdom
10Charité-Universitätsmedizin Berlin, Berlin, Germany
11Hematology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain
12Avillion LLP, London, United Kingdom
13Pfizer, Collegeville, PA
14Pfizer, Cambridge, MA
15Global Research and Development, Pfizer International Operation-Oncology, Paris, France
16Universitätsklinikum RWTH Aachen, Aachen, Germany
17Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Emir Hadzijusufovic, DVM1,2,3*, Gregor Hoermann, MD4, Susanne Herndlhofer2*, Wolfgang R. Sperr, MD5*, Bernd Jilma, MD6, Gerit H. Schernthaner, MD7* and Peter Valent, MD2,8

1Department for Companion Animals and Horses, University Clinic for Small Animals, Internal Medicine Small Animals, University of Veterinary Medicine Vienna, Vienna, Austria
2Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
3Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria
4Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria
5Department of Medicine I, Division of Hematology and Hemostaseology, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
6Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
7Department of Medicine II, Division of Angiology, Medical University of Vienna, Vienna, Austria
8Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria

Michael J. Mauro, MD1, Carlo Gambacorti-Passerini, MD2, Michael W. Deininger, MD, PhD3, Charles Chuah, MD4, Dong-Wook Kim, MD, PhD5, Iryna Dyagil, MD PhD6*, Natalia Glushko7*, Dragana Milojkovic, MBBS, PhD8*, Philipp D. le Coutre, MD9, Valentín García Gutiérrez, PhD10, Laurence Reilly11*, Allison Jeynes-Ellis11*, Rocco J. Crescenzo, DO, FACOI12*, Roberto Uehara12*, Eric Leip, PhD13*, Liza DeAnnuntis12*, Nathalie Bardy-Bouxin, PhD14*, Andreas Hochhaus, MD15, Timothy H. Brümmendorf16 and Jorge E. Cortes, MD17

1Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, New York, NY
2University of Milano-Bicocca, San Gerardo Hospital, Monza, Italy
3University of Utah, Salt Lake City, UT
4Singapore General Hospital and Duke-NUS Medical School, Singapore, Singapore
5Seoul St. Mary’s Hospital, Leukemia Research Institute, The Catholic University of Korea, Seoul, Korea, Republic of (South)
6Hematology, National Research Center For Radiation Medicine, Kiev, UKR
7Ivano-Frankivsk Regional Clinical Hospital, Ivan0-Frankivsk, Ukraine
8Department of Haematology, Hammersmith Hospital, Imperial College, London, United Kingdom
9Charité-Universitätsmedizin Berlin, Berlin, Germany
10Hematology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain
11Avillion LLP, London, United Kingdom
12Pfizer, Collegeville, PA
13Pfizer, Cambridge, MA
14Global Research and Development, Pfizer International Operation-Oncology, Paris, France
15Klinik für Innere Medizin II, Jena, DEU
16Universitätsklinikum RWTH Aachen, Aachen, Germany
17Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Naranie Shanmuganathan, MBBS1,2,3,4,5, Susan Branford, PhD6,7, David Yeung, PhD, BSc, FRACP, FRCPA, MBBS1,2,3,5, Devendra K Hiwase, MBBS, MD, FRACP, FRCPA, PhD2,3,5,8, Agnes S. M. Yong, MD, PhD2,3,5, David M Ross, MBBS, PhD, FRACP, FRCPA2,5,9,10,11,12* and Timothy P. Hughes, MD, MBBS, FRACP, FRCPA1,2,3,4,5

1Department of Haematology, Royal Adelaide Hospital, Adelaide, Australia
2Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, Australia
3School of Medicine, University of Adelaide, Adelaide, Australia
4Haematology Society of Australia & New Zealand, Sydney, Australia
5Department of Haematology, SA Pathology, Adelaide, Australia
6Genetic and Molecular Pathology, Centre for Cancer Biology, SA Pathology, Adelaide, Australia
7School of Pharmacy and Medical Science, University of South Australia, Adelaide, Australia
8Department of Haematology, Royal Adelaide Hospital, Adelaide, SA, Australia
9Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, Australia
10School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, Australia
11Haematology and Genetic Pathology, Flinders University, Adelaide, Australia
12Flinders University, Bedford Park, Australia

Dennis Kim, MD1, Isabelle Bence-Bruckler2*, Donna L Forrest, MD3*, Lynn Savoie4*, Stephen Couban, MD, BSc5, Lambert Busque, MD6, Robert Delage7*, Pierre Laneuville, MD, FRCPC8, Elena Liew, MD, BSc, FRCPC9, Anargyros Xenocostas, MD10, Kristjan Paulson, MD11, Suzanne Kamel-Reid12, Jeffrey H. Lipton, PhD, MD, FRCPC13* and Brian Leber, MD14

1Blood and Marrow Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
2The Ottawa Hospital Research Institute, Ottawa, ON, CAN
3Leukemia/Bone Marrow Transplant Program of British Columbia, BC Cancer Agency, Vancouver, BC, Canada
4University of Calgary, Calgary, AB, Canada
5Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
6Hôpital Maisonneuve Rosemont, Montreal, QC, Canada
7Service d hematologie et d oncologie, CHU de Quebec, Hôpital de l'Enfant Jesus, Quebec, QC, Canada
8McGill University Health Centre, Montreal, QC, Canada
9University of Alberta Hospital, Edmonton, AB, CAN
10London Health Sciences Centre, Victoria Hospital, London, ON, CAN
11Cancercare Manitoba, Winnipeg, MB, CAN
12Advanced Molecular Diagnostics Laboratory, University Health Network, Toronto, ON, Canada
13University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada
14Juravinski Hospital and Cancer Centre, Hamilton, ON, CAN

Hamzah Munir Alqam, MD1*, Hagop M. Kantarjian, MD2, Dai Chihara, MD, PhD3,4, Koji Sasaki, MD2, Elias J. Jabbour, MD 5 and Jorge E. Cortes, MD2

1Department of Internal Medicine, University of New Mexico, Albuquerque
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, The University of New Mexico Health Sciences Center, Albuquerque, NM
4Internal Medicine, University of New Mexico, Albuquerque
5Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX

Valentín García Gutiérrez, PhD1, Andrés Novo, MD2*, Antonio Jimenez-Velasco3*, Luis Felipe Casado Montero, MD4, Fermin Sanchez-Guijo, MD, PhD5*, Raul Perez Lopez6*, Santiago Osorio-Prendes7*, Sunil Lakhwani Lakhwani8*, Angel Ramirez Payer9*, Guillermo Orti10*, Maria Teresa Gomez-Casares11*, Juan Manuel Alonso12*, Manuel Pérez-Encinas13*, Rolando Vallansot14*, Ernesto Pérez Persona15*, Maria Angeles Portero Frias16*, María José Ramírez Sánchez17*, Maria Alicia Senin18*, Gonzalo Caballero19*, Soledad Noya20*, Concepcion Boque21*, Maribel Mata22*, Mario Romo23*, Juan Luis Steegmann, MD, PhD24 and Juan Carlos Hernandez-Boluda, MD25*

1Servicio de Hematología, Hospital Universitario Ramon y Cajal. IRYCIS, Madrid, Spain
2Hospital Son Espases, Palma de Mallorca, Spain
3Hematology Department & IIS-IP, Hospital Universitario de la Princesa, Madrid, Spain, Malaga, Spain
4Hospital Virgen de la Salud, Toledo, ESP
5Hematology Department, Hospital Clínico Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain
6Servicio de Hematología, Hospital Universitario Clínico Virgen de la Arrixaca, MURCIA, ESP
7Servicio de Hematología, Hospital Universitario Gregorio Marañón, Madrid, Spain
8Hospital Universitario de Gran Canarias, La Laguna, La Laguna, ESP
9Servicio de Hematologia, Hospital Universitario Central de Asturias, Oviedo, ESP
10ph, Hematology Department, Hospital Universitari Vall d´Hebron, VHIO, Barcelona, Spain
11Hospital Universitario De Gran Canaria Dr, Negrin, Spain
12Hospital Universitario Fundación Jiménez Díaz, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), UAM, Madrid, Spain
13Haematology Department, Hospital Clínico, Sanatiago De Compostela, ESP
14Servei d´Hematologia, ICO-Tarragona, Hospital Universitari Joan XXIII, TARRAGONA, ESP
15Hospital de Txagorritxu, Vitoria, Spain
16Hospital Universitario Virgen Macarena, SEVILLA, ESP
17Hospital Universitario de Jérez, Jerez De La Frontera., ESP
18Hematology Department, Hospital del Mar-IMIM, Barelona, Spain
19Servicio de Hematologia. Hospital Universitario Miguel Servet, Zaragoza, Spain
20Servicio de Hematología, Complejo Hospitalario Universitario A Coruña, La Coruña, Spain
21Hospital Duran i Reinals, Institut Català d'Oncologia, Barcelona, Spain
22Servicio de Hematología. Hospital Costa del Sol, Malaga, Spain
23Servicio de Hematologia. Hospital Alvaro Cunqueiro, Vigto, Spain
24Hospital Universitario de la Princesa, Madrid, ESP
25Hematology Department, Hospital Clínico Universitario, Valencia, Spain

Gabriele Gugliotta, MD, PhD1, Fausto Castagnetti, MD2, Massimo Breccia, M.D., PhD3*, Mariella D'adda4*, Fabio Stagno, MD, PhD5, Luciano Levato, MD6*, Angelo Michele Carella, MD7*, Bruno Martino8*, Mario Tiribelli, MD9*, Carmen Fava, MD, PhD10*, Antonella Gozzini, MD11*, Marzia Salvucci, MD12*, Michele Cedrone, MD13*, Elena Trabacchi, MD14*, Emilio Usala, MD15*, Anna Rita Scortechini, MD16*, Luigia Luciano, MD17, Simona Soverini, PhD18, Michele Cavo, MD19*, Giovanni Martinelli, MD20, Fabrizio Pane, MD21, Giuseppe Saglio, MD, PhD22, Michele Baccarani, MD23* and Gianantonio Rosti, MD24*

1Department of Experimental Diagnostic and Specialty Medicine - DIMES Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Bologna, Italy
2"S.Orsola-Malpighi" University Hospital; University of Bologna, Bologna, ITA
3Department of Cellular Biotechnologies and Hematology, University La Sapienza, Rome, Italy
4Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
5Chair and Hematology Section, Ferrarotto Hospital, Catania, Italy
6Department Hematology-Oncology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy
7IRCCS Azienda Ospedaliera Universitaria San Martino, IST Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
8Azienda Ospedaliera "Bianchi Melacrino Morelli", Reggio Calabria, Italy
9Division of Hematology and Stem Cell Transplantation, Azienda Sanitaria Universitaria Integrata, Udine, Italy
10Department of Clinical and Biological Sciences, University of Turin, Orbassano (TO), Italy
11SC Terapie Cellulari e Medicina Trasfusionale, AOU Careggi, Florence, Italy
12Hematology Unit, S. Maria delle Croci Hospital, Ravenna, Italy
13UOC of Hematology, San Giovanni - Addolorata Hospital, Rome, Italy
14Hematology Unit, Guglielmo da Saliceto Hospital, Piacenza, Italy
15Hematology and Bone Marrow Transplantation Unit, Ospedale Oncologico di Riferimento Regionale "Armando Businco", Cagliari, Italy
16Hematology Unit, Ospedali Riuniti University Hospital, Ancona, Italy
17Federico II University, Napoli, ITA
18Hematology/Oncology "L. e A. Seragnoli", University of Bologna, Bologna, ITA
19Department of Physics and Astronomy, University of Bologna, Bologna, Italy
20Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology “ L. and A. Seràgnoli”, University of Bologna, Bologna, Italy, Bologna, Italy
21Hematology - Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy
22Department of Clinical and Biological Sciences, University of Turin, Orbassano, Turin, Italy
23Institute of Hematology " L. & A. Seràgnoli", St. Orsola University Hospital, Bologna, Italy
24Department of Experimental, Diagnostic and Specialty Medicine - DIMES, Institute of Hematology "L. and A. Seràgnoli", S.Orsola-Malpighi University Hospital, Bologna, Italy

Srinivas K. Tantravahi, MBBS1, Gwendolyn A. McMillin, PhD2*, Phillip M. Clair, MS3*, Aaron J. Sadler2*, Tracy Dowell, BS2*, Janice Geier, MT4*, Philip S. Bernard, MD5* and Michael W. Deininger, MD, PhD3

1Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
2ARUP Laboratories, Salt Lake City, UT
3Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT
4Oregon Health & Science University, Portland, OR
5University of Utah / Huntsman Cancer Institute, Salt Lake City, UT

Sameer Ahmad Guru1*, Musadiq Ahmad Bhat, MSc.2*, Imtiyaz Ahmad Najar, Ph.D3*, Ab. Rashid Rashid, Ph.D4*, Mariyam Zuberi, Ph.D5*, Mamta Sumi Sumi, PhD6*, Naresh Gupta, MD3*, Alpana Saxena3* and Ajay Sharma, MD7

1Maulana Azad Medical College, University of Delhi, New delhi, DE, India
2Biochemistry, Maulana azad medical college, New Delhi, India
3Maulana azad medical college, New Delhi, India
4university of Tabuk, Saudi, Saudi Arabia
5biochemistry, Maulana azad medical college, New Delhi, India
6Biochemistry, Maulana azad medical college, new delhi, India
7Ganga Ram IPMER, New Delhi-60, IND

Simone Claudiani, MD1,2*, Adi Shacham Abulafia3*, Ira Sabli, BSc1*, Richard Szydlo, PhD1*, Dragana Milojkovic, MBBS, PhD2*, George Nesr, MD1,2*, Renuka Palanicawander, MD2*, George Nteliopoulos1*, Mary Alikian1*, Jamshid S Khorashad, MD, PhD1*, Letizia Foroni, MD, PhD1* and Jane F. Apperley, FRCP, FRCPath, MD, MBChB1,2

1Centre for Haematology, Imperial College London at Hammersmith Hospital, London, United Kingdom
2Department of Haematology, Hammersmith Hospital (Imperial College Healthcare NHS Trust), London, United Kingdom
3Institute of Hematology, Davidoff Cancer Centre, Beilinson Hospital, Rabin Medical Centre, Petah-Tiqva, Israel

Simone Claudiani, MD1,2*, Aoife Gatenby, BSc2*, Richard Szydlo, PhD2*, Dragana Milojkovic, MBBS, PhD1*, Emily Ching2*, George Nesr, MD1,2*, Renuka Palanicawander, MD1*, George Nteliopoulos2*, Mary Alikian2*, Jamshid S Khorashad, MD, PhD2*, Letizia Foroni, MD, PhD2* and Jane F. Apperley, FRCP, FRCPath, MD, MBChB1,2

1Department of Haematology, Hammersmith Hospital (Imperial College Healthcare NHS Trust), London, United Kingdom
2Centre for Haematology, Imperial College London at Hammersmith Hospital, London, United Kingdom

*signifies non-member of ASH